Mirum CEO Chris Peetz said in a statement that Livmarli could have a transformational impact for patients with cholestatic pruritis associated with PFIC. March 11: In a press release Monday, Viatris and Mapi Pharma announced that the FDA has rejected their multiple sclerosis hopeful GA Depot 40, which the companies had proposed as a treatment for relapsing forms of the disease
Semaglutide is a GLP-1 receptor agonist as well as a glucagon-like peptide-1 receptor agonist
This is intriguing but its very much at the experimental fringes, not established clinical practice
Here are some other handy tips for weight management: Aim for steady weight loss rather than instant results as they are not sustainable
Once treatment begins, you receive regular follow-up appointments that include weight and body composition tracking, lab work review, side effect management, nutritional counseling, and dose adjustment as needed